LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 91.27 | 84.90 | 1952 | 7420 | 0.2631 | 0.6260 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 91.27 | 84.90 | 6314 | 7420 | 0.8509 | 0.9506 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 92.98 | 84.90 | 87 | 7257 | 0.0120 | 0.0038 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 92.98 | 84.90 | 5437 | 7257 | 0.7491 | 0.9120 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 92.98 | 84.90 | 1407 | 7257 | 0.1939 | 0.5488 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 92.98 | 84.90 | 6400 | 7257 | 0.8818 | 0.9612 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 94.68 | 84.90 | 46 | 7000 | 0.0066 | -0.0918 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 94.68 | 84.90 | 5427 | 7000 | 0.7752 | 0.9216 | MN20160318_Q02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 94.68 | 84.90 | 1378 | 7000 | 0.1969 | 0.5493 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 94.68 | 84.90 | 6478 | 7000 | 0.9254 | 0.9758 | MN20160318_Q02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 2.66 | 84.90 | 585 | 285 | 2.0473 | 2.0113 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 2.66 | 84.90 | 520 | 285 | 1.8198 | 1.8154 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 4.36 | 84.90 | 677 | 322 | 2.0988 | 1.9391 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 4.36 | 84.90 | 617 | 322 | 1.9128 | 1.8008 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 6.06 | 84.90 | 3 | 365 | 0.0082 | -0.7955 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 6.06 | 84.90 | 769 | 365 | 2.1042 | 1.8474 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 6.06 | 84.90 | 720 | 365 | 1.9702 | 1.7598 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 7.77 | 84.90 | 7 | 411 | 0.0170 | -0.6659 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 7.77 | 84.90 | 860 | 411 | 2.0912 | 1.7656 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | F04 |